Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May;19(5):e70106.
doi: 10.1111/irv.70106.

An Improved Rapid and Sensitive Long Amplicon Method for Nanopore-Based RSV Whole-Genome Sequencing

Affiliations

An Improved Rapid and Sensitive Long Amplicon Method for Nanopore-Based RSV Whole-Genome Sequencing

Xiaomin Dong et al. Influenza Other Respir Viruses. 2025 May.

Abstract

Background: Whole-genome sequencing (WGS) provides critical insights into the respiratory syncytial virus (RSV) transmission and any emerging mutations that could impair the efficacy of monoclonal antibodies or vaccines that have been recently licenced for clinical use worldwide. However, the ability to sequence RSV genomes at large scale is limited by expensive and time-consuming sequencing methods. Oxford Nanopore Technology (ONT) offers significant improvements in next generation sequencing (NGS) both in turnaround time and cost, compared with other platforms for viral WGS.

Methods: We have developed and modified an RSV long amplicon-based WGS protocol for the ONT platform using a one-step multiplex RT-PCR assay and the rapid barcoding kit. One hundred thirty-five RSV positive Australian clinical specimens (91 RSV-A and 44 RSV-B) sampled in 2023 with cycle threshold (Ct) values between 14 to 35 were tested in this study. This ONT workflow was compared with other recent RSV WGS amplification assays based on short amplicons.

Results: A PCR amplicon clean-up step prior to library preparation significantly improved WGS result for samples with poor amplicon generation, but it is not necessary or beneficial for ones that generated high concentrations of amplicons. Overall, a success rate of 85.9% was achieved for WGS. This method performed as well as the more complex short amplicon methods in terms of genome coverage and sequencing depth.

Conclusions: The workflow described here was highly successful in generating RSV WGS on ONT platform and had improved turnaround times and excellent results with RSV clinical samples with Ct values up to 30.

Keywords: ONT; rapid barcoding; respiratory syncytial virus; whole‐genome sequencing.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
The performance of ONT rapid barcoding method mediated NGS with library preparation from samples with sufficient amplicons. (A) Histograms of the Ct value distribution for clinical samples having sufficient (dark green) and insufficient (dark red) amplicons generated for ONT libraries. (B) Histograms of the Ct value distribution for clinical samples within sufficient amplicons group with RSV full‐length genome (blue), G plus F genes (brown), only G gene (dark red) and missing G and F gene sequenced (also called ‘other’), respectively. (C) Coverage depth of sequenced representative RSV‐A (red) and RSV‐B (blue) in genomic position covered by six overlapping amplicons. (D) Histograms of the Ct value distribution for clinical samples within sufficient amplicons group having RSV whole genome (blue), G plus F genes (brown), only G gene (dark red) and missing G and F gene sequenced (also called ‘other’ in dark green), whole genome rescued by DNA purification (purple), respectively. Coverage depth of sequenced representative RSV‐A (E) and RSV‐B (F) in genomic position with (blue) and without (red) PCR amplicon clean‐up. Bar plots showing the fold change of NGS reads mapped to RSV reference genomes from sequenced samples of low (G) and high (H) concentration of amplicons generated without and with PCR amplicon purification. NGS reads of libraries from washed PCR amplicons were normalised and expressed as fold changes to ones from unwashed PCR amplicons that were set to 1. Data are expressed as mean ± SD. t‐test analysis was performed for statistical significance. P values less than 0.05 were considered as statistically significant and labelled as * in the figures.
FIGURE 2
FIGURE 2
RSV NGS achieved by one long and two short amplicon‐based RSV WGS assays. Coverage depth of sequenced representative RSV‐A (A) and RSV‐B (B) in genomic position with long amplicon‐based (red), Maloney's short amplicon‐based (green) and Talts' short amplicon‐based (blue) assays.
FIGURE 3
FIGURE 3
Phylogenetic analysis of full‐length of RSV‐A and RSV‐B. (A) Phylogenetic analysis of full‐length of RSV‐A generated using the ONT workflow described in this method. RSV‐A full‐length genome sequences generated using this method were analyzed phylogenetically and showed that the RSV‐A genomes clustered into 3 main clades. (B) Phylogenetic analysis of full‐length of RSV‐B generated using the ONT workflow described in this method. RSV‐B full‐length genome sequences generated using this method were analysed phylogenetically and showed that the RSV‐B genomes clustered into two main clades.
FIGURE 4
FIGURE 4
Schematic diagram of ONT NGS workflow for RSV WGS based on a long PCR amplicon assay.

Similar articles

References

    1. Lozano R., Naghavi M., Foreman K., et al., “Global and Regional Mortality From 235 Causes of Death for 20 age Groups in 1990 and 2010: A Systematic Analysis for the Global Burden of Disease Study 2010,” Lancet 380, no. 9859 (2012): 2095–2128. - PMC - PubMed
    1. Shi T., McAllister D. A., O'Brien K. L., et al., “Global, Regional, and National Disease Burden Estimates of Acute Lower Respiratory Infections due to Respiratory Syncytial Virus in Young Children in 2015: A Systematic Review and Modelling Study,” Lancet 390, no. 10098 (2017): 946–958. - PMC - PubMed
    1. Wilkins D., Yuan Y., Chang Y., et al., “Durability of Neutralizing RSV Antibodies Following Nirsevimab Administration and Elicitation of the Natural Immune Response to RSV Infection in Infants,” Nature Medicine 29, no. 5 (2023): 1172–1179. - PMC - PubMed
    1. Ison M. G., Papi A., Athan E., et al., “Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons,” Clinical Infectious Diseases 78, no. 6 (2024): 1732–1744. - PMC - PubMed
    1. Mazur N. I., Terstappen J., Baral R., et al., “Respiratory Syncytial Virus Prevention Within Reach: The Vaccine and Monoclonal Antibody Landscape,” Lancet Infectious Diseases 23, no. 1 (2023): e2–e21. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources